Description
Your eye doctor may prescribe Neptazane to treat glaucoma, a condition involving increased eye pressure that can lead to vision loss. Glaucoma often affects older adults and can cause symptoms like eye pain, headaches, halos around lights, decreased vision, nausea, and vomiting.
Methazolamide, the active ingredient in Neptazane, is a carbonic anhydrase inhibitor that reduces the production of aqueous humor (the fluid in the eye), lowering intraocular pressure.
Fact Table
|
Formula
|
C5H8N2O3S2
|
License
|
US FDA
|
Bioavailability
|
~100%
|
Legal status
|
Prescription only (?)
|
Chemical Name
|
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2-yl]acetamide
|
Elimination half-life
|
14 hours
|
Dosage (Strength)
|
25 mg, 50 mg tablets
|
Pregnancy
|
Not recommended
|
Brands
|
Neptazane
|
Protein binding
|
~55%
|
PubChem CID
|
4068
|
MedlinePlus
|
a682091
|
ChEBI
|
CHEBI:6796
|
ATC code
|
S01EC02
|
DrugBank
|
DB00812
|
KEGG
|
D02388
|
Routes of administration
|
Oral
|
Directions
The usual dosage of Neptazane is 50-100 mg by mouth 2-3 times daily with or without food.
Ingredients
The active ingredient in Neptazane is methazolamide.
Interactions
Tell your doctor and pharmacist if you are taking any of the following drugs:
- Aspirin
- Levoketoconazole
- Memantine
- Metformin
- Methotrexate
- Topiramate
Cautions
Before starting Neptazane, tell your doctor about any history of kidney or liver disease, electrolyte imbalances, or blood disorders.
Your healthcare team should regularly monitor blood electrolytes and kidney function, as methazolamide can cause significant electrolyte disturbances.
Methazolamide can also increase the risk of metabolic acidosis, especially in diabetic patients. Symptoms such as confusion, rapid heartbeat, fatigue, or rapid breathing require immediate medical attention.
Severe reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported with sulfonamide use, though they are rare. If suspected, discontinue use immediately.
Severe hematologic reactions have also been reported, including agranulocytosis and aplastic anemia.
Methazolamide can cause severe liver reactions, including fulminant hepatic necrosis. Hepatic coma may occur in patients with cirrhosis or hepatic insufficiency.
Hypersensitivity reactions may recur with sulfonamide administration.
Patients with pulmonary conditions like emphysema may experience aggravated acidosis.
Side Effects
Common adverse reactions to Neptazane can include:
- Agranulocytosis
- Aplastic anemia
- Confusion
- Diarrhea
- Disorder of taste
- Electrolyte imbalance
- Fatigue
- Fulminant liver failure
- Hepatic necrosis
- Loss of appetite
- Malaise
- Metabolic acidosis
- Myopia
- Nausea
- Neutropenia
- Paresthesia
- Polyuria
- Pure red cell aplasia
- Somnolence
- Stevens-Johnson syndrome
- Thrombocytopenia
- Tinnitus
- Toxic epidermal necrolysis
- Vomiting
References
Methazolamide [package insert]. Vaughan, Ontario: AA Pharma; July 2010.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 5365